New Insights into Coronary Artery Disease (CAD)

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 25 September 2024 | Viewed by 1962

Special Issue Editor


E-Mail Website
Guest Editor
Cardiac Catheterization Laboratory, Montevergine Clinic, Mercogliano, Italy
Interests: coronary artery disease; coronary physiology; carotid artery stenting; percutaneous treatment of valvular disease

Special Issue Information

Dear Colleagues,

Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide, encompassing a wide range of conditions that span from asymptomatic stable coronary plaque to acute myocardial infarction with hemodynamic or electrical instability.

Pharmaceutical and technological advancements have recently led to a significant improvement in both the medical and interventional treatment of patients with CAD. However, there is still much to do, especially in terms of prevention and in order to improve the long-term outcomes of PCI and stenting.

This Special Issue aims to provide a comprehensive platform for the dissemination of the latest advancements and discoveries related to CAD. By delving into novel insights, this Special Issue aims to enhance our understanding of the complexities of CAD and promote the translation of scientific discoveries into clinical practice.

In this Special Issue, entitled “New Insights into Coronary Artery Disease”, we invite the submission of manuscripts regarding the latest information on the topic, including original clinical studies and reviews.

Dr. Giuseppe Di Gioia
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • coronary artery disease
  • chronic coronary syndrome
  • acute coronary syndrome
  • percutaneous coronary intervention
  • cardiac arrest

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 1246 KiB  
Article
Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation
by Sofia Sammartino, Giulia Laterra, Thomas Pilgrim, Ignacio J. Amat Santos, Ole De Backer, Won-Keun Kim, Henrique Barbosa Ribeiro, Francesco Saia, Matjaz Bunc, Didier Tchetche, Philippe Garot, Flavio Luciano Ribichini, Darren Mylotte, Francesco Burzotta, Yusuke Watanabe, Francesco Bedogni, Tullio Tesorio, Tobias Rheude, Gennaro Sardella, Marco Tocci, Anna Franzone, Roberto Valvo, Mikko Savontaus, Hendrik Wienemann, Italo Porto, Caterina Gandolfo, Alessandro Iadanza, Alessandro Santo Bortone, Markus Mach, Azeem Latib, Luigi Biasco, Maurizio Taramasso, Federico De Marco, Valentina Frittitta, Elena Dipietro, Claudia Reddavid, Orazio Strazzieri, Silvia Motta, Alessandro Comis, Chiara Melfa, Mariachiara Calì, Carmelo Sgroi, Mohamed Abdel-Wahab, Giulio Stefanini, Corrado Tamburino, Marco Barbanti and Giuliano Costaadd Show full author list remove Hide full author list
J. Clin. Med. 2024, 13(12), 3497; https://doi.org/10.3390/jcm13123497 - 14 Jun 2024
Viewed by 628
Abstract
Background/Objectives: To date, data regarding the characteristics and management of obstructive, stable coronary artery disease (CAD) encountered in patients undergoing transcatheter aortic valve implantation (TAVI) are sparse. The aim of the study was to analyze granular details, treatment, and outcomes of patients [...] Read more.
Background/Objectives: To date, data regarding the characteristics and management of obstructive, stable coronary artery disease (CAD) encountered in patients undergoing transcatheter aortic valve implantation (TAVI) are sparse. The aim of the study was to analyze granular details, treatment, and outcomes of patients undergoing TAVI with obstructive, stable CAD from real-world practice. Methods: REVASC-TAVI (Management of myocardial REVASCularization in patients undergoing Transcatheter Aortic Valve Implantation with coronary artery disease) is an investigator-initiated, multicenter registry, which collected data from patients undergoing TAVI with obstructive stable CAD found during the pre-TAVI work-up. Results: A total of 2025 patients from 30 centers worldwide with complete follow-up were included in the registry. Most patients had single-vessel CAD (56.1%). An involvement of proximal coronary tracts was detected in 62.5% of cases, with 12.0% of patients having CAD in left main (LM). Most patients received percutaneous coronary intervention (PCI) (n = 1617, 79.9%), especially those with proximal CAD (90.4%). At 2 years, the rates of all-cause death [Kaplan–Meier (KM) estimates 20.1% vs. 18.8%, plog-rank = 0.86] and of the composite of all-cause death, stroke, myocardial infarction, and rehospitalization for heart failure (KM estimates 29.7% vs. 27.5%, plog-rank = 0.82) did not differ between patients undergoing PCI and those who were not. Conclusions: Patients undergoing TAVI with obstructive CAD more commonly had a single-vessel disease and an involvement of proximal coronary tracts. They were commonly treated with PCI, with similar outcomes compared to those treated conservatively. Full article
(This article belongs to the Special Issue New Insights into Coronary Artery Disease (CAD))
Show Figures

Figure 1

11 pages, 1472 KiB  
Article
Are Thiols Useful Biomarkers for Coronary Collateral Circulation in Patients with Stable Coronary Artery Disease?
by Yasemin Doğan, Yücel Yilmaz, Saban Kelesoğlu, Bekir Calapkorur, Salim Neşelioglu, Özcan Erel and Nihat Kalay
J. Clin. Med. 2023, 12(19), 6361; https://doi.org/10.3390/jcm12196361 - 4 Oct 2023
Cited by 1 | Viewed by 915
Abstract
Our aim was to investigate the relationship between thiol, which is the main component of the antioxidant system, and coronary collateral circulation (CCC). Our patients consisted of people with stable coronary artery disease (sCAD) and total occlusion in at least one vessel ( [...] Read more.
Our aim was to investigate the relationship between thiol, which is the main component of the antioxidant system, and coronary collateral circulation (CCC). Our patients consisted of people with stable coronary artery disease (sCAD) and total occlusion in at least one vessel (n = 249). We divided the patients into two groups, good and poor, according to their CCC degree. We determined that DM, total thiol, and disulfide are independent predictors of poor CCC in multivariate logistic regression analysis (OR: 1.012, 95% CI: 1.008–1.017, p < 0.001; OR: 1.022, 95% CI: 1.000–1.044, p = 0.044; OR: 2.671, 95% CI: 1.238–5.761, p = 0.012, respectively). The ROC analysis showed a cut-off value of 328.7 for native thiol regarding the prediction of poor CCC, with 67.4% specificity and 78% sensitivity. For disulfide, it revealed a cut-off value of 15.1 regarding the prediction of poor CCC, with 57.9% specificity and 69.5% sensitivity. In this study, we detected that the patients with sCAD who developed poor CCC had lower levels of native thiol, total thiol, and disulfide compared to those with good CCC. The most interesting finding of our study is that CCC formation is an effective predictor of the antioxidant cascade rather than the inflammation cascade in sCAD patients. Full article
(This article belongs to the Special Issue New Insights into Coronary Artery Disease (CAD))
Show Figures

Figure 1

Back to TopTop